Seer Inc. Class A (SEER)
NASDAQ: SEERIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SEER stock chart
Technical analysisKey statistics
All statistics- Market cap
- $75.91M
- EPS (TTM)
- -$1.14
- Dividend yield
- None
- 52-week range
- 1.33 – 2.38
- Day range
- 1.33 – 1.43
- Volume / Avg
- 130.28K / 216.28K
- Beta
- —
- Shares outstanding
- 55.81M
52-week range
SEER stock today
Seer (SEER) closed at $1.36 on Nov 20, down 1.81% (-$0.025), versus the S&P 500's 3.70% decline. Shares are 42.7% below their 52-week high of $2.38, set on Oct 5, 2026 and 2.3% above the 52-week low of $1.33, near the bottom of the past year's range. SEER is down 25.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 31.0%.
Seer has posted a net loss over the last twelve months (EPS of -$1.14), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Seer
Company profileSeer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Dr. Omid C. Farokhzad M.D., Ph.D.
- Headquarters
- Redwood City, CA
- Employees
- 124
- IPO year
- 2020
- Website
- seer.bio
Financial highlights
Full financialsIn fiscal 2025, Seer generated $16.6 million in revenue, up 17.0% from fiscal 2024. Seer reported a net loss of $73.6 million, compared with a loss of $86.6 million a year earlier. Gross margin was 51.1% (up from 49.8%) and operating margin -470.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $16.58M | $14.17M | $16.66M | $15.49M | $6.62M |
| Growth | +16.99% | -14.95% | +7.54% | +134.14% | +908.69% |
| Net income | $-73.60M | $-86.60M | $-86.28M | $-92.97M | $-71.17M |
| EPS (diluted) | — | — | $-1.35 | $-1.49 | $-1.17 |
Analyst forecast
ForecastConsensus (2 analysts)
strong_buy
Avg. price target
$4.00+194.12%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $-0.32 vs —
SEER news
All SEER newsSeer peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QTRXQuanterix Corporation | 1.96 | -3.45% | $93.06M | vs SEER |
| HBIOHarvard Bioscience Inc. | 8.66 | -0.23% | $39.60M | vs SEER |
| RPIDRapid Micro Biosystems Inc. Class A | 0.735 | -0.04% | $37.37M | vs SEER |
| PRPOPrecipio Inc. | 17.35 | -6.17% | $31.11M | vs SEER |
| EYPTEyePoint Inc. | 0.2342 | -11.36% | $26.65M | vs SEER |
| CIRCCircle8 Group Inc. | 0.1361 | -12.25% | $15.99M | vs SEER |
| BNGOBionano Genomics Inc. | 0.8222 | -7.11% | $11.50M | vs SEER |
| ASTCAstrotech Corporation (DE) | 3.50 | -0.85% | $7.45M | vs SEER |
Indexes, lists and sector
Seer stock FAQ
What is Seer's stock price today?
SEER last traded at $1.36 as of Nov 20, 4:00 PM EST, down 1.81% on the day. Prices are delayed at least 15 minutes.
Who is Seer's CEO?
Dr. Omid C. Farokhzad M.D., Ph.D. is the chief executive officer of Seer Inc. Class A, which has about 124 employees.
What is the SEER 52-week high?
The 52-week high for SEER is $2.38 and the 52-week low is $1.33. The stock is currently 42.7% below its high.